These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 27639107)
1. Bioresorbable scaffolds are here, please handle with care. Waksman R Cardiovasc Revasc Med; 2016 Sep; 17(6):353-4. PubMed ID: 27639107 [No Abstract] [Full Text] [Related]
2. Why Bioresorbable Vascular Scaffold Should Be Approved for Marketing in the United States. Waksman R Cardiovasc Revasc Med; 2015; 16(7):379-80. PubMed ID: 26573413 [No Abstract] [Full Text] [Related]
3. So We Have Bioresorbable Scaffolds: Now What? King SB JACC Cardiovasc Interv; 2016 May; 9(10):1087-8. PubMed ID: 27198690 [No Abstract] [Full Text] [Related]
4. Polymeric bioresorbable coronary scaffolds: the hype is over, but the dream lives on. Pyxaras SA; Wijns W EuroIntervention; 2018 Jan; 13(13):1506-1509. PubMed ID: 29345240 [No Abstract] [Full Text] [Related]
5. The future of bioresorbable vascular scaffolds: niche or workhorse devices? Lahoud R; Ellis S Coron Artery Dis; 2017 Sep; 28(6):449-451. PubMed ID: 28644214 [No Abstract] [Full Text] [Related]
6. Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions. Jabbour RJ; Tanaka A; Capranzano P; Cortese B; Lesiak M; Testa L; Gatto P; Suarez de Lezo J; Mattesini A; Geraci S; Ielasi A; Diletti R; Capodanno D; Buccheri D; Iwanczyk S; Bedogni F; Tchetche D; Di Mario C; Caramanno G; Van Mieghem NM; Tamburino C; Colombo A; Latib A JACC Cardiovasc Interv; 2017 Apr; 10(7):743-745. PubMed ID: 28385415 [No Abstract] [Full Text] [Related]
7. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth. Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762 [No Abstract] [Full Text] [Related]
8. Bioresorbable vascular scaffolds: the shape of things to come? Safian RD Catheter Cardiovasc Interv; 2012 Sep; 80(3):472-3. PubMed ID: 22431381 [No Abstract] [Full Text] [Related]
9. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648 [TBL] [Abstract][Full Text] [Related]
10. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition. Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613 [No Abstract] [Full Text] [Related]
11. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis. Lee WC; Fang HY; Fang CY Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437 [No Abstract] [Full Text] [Related]
12. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
13. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds. Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830 [TBL] [Abstract][Full Text] [Related]
14. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives. Kitabata H; Waksman R; Warnack B Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760 [TBL] [Abstract][Full Text] [Related]
15. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures? Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134 [No Abstract] [Full Text] [Related]
16. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds. Gori T; Schulz E; Münzel T JACC Cardiovasc Interv; 2014 Oct; 7(10):1194-5. PubMed ID: 25240537 [No Abstract] [Full Text] [Related]
17. Unexpected entrapment of a guidewire by bioresorbable vascular scaffold deployment at a calcified coronary lesion. Lee WC; Fang HY; Sung PH; Yeh KH; Wu CJ EuroIntervention; 2016 Sep; 12(7):874. PubMed ID: 27639740 [No Abstract] [Full Text] [Related]
18. A very late thrombosis in a bioresorbable vascular scaffold. Giacchi M; Pedrazzini G; Moccetti T; Moccetti M EuroIntervention; 2015 Nov; 11(7):e1. PubMed ID: 26603865 [No Abstract] [Full Text] [Related]
19. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem. Foin N; Lee R; Wong P; Low AF EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237 [No Abstract] [Full Text] [Related]
20. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution? Granata F; Moscarella E; Varricchio A Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019 [No Abstract] [Full Text] [Related] [Next] [New Search]